In onestudy, exposure of HCC cells to sorafenib led to changes in UPR that affectedAFP production independent of an effect on cell viability, a finding thatsuggests that AFP could potentially serve as a biomarker of tumor proteostaticresponse[29]. Here, AFP is linked to hepatocellular carcinoma.